golexanolone
AssetAlso GR3027
Antagonizes neurosteroid-mediated enhancement of GABA-A receptor signaling.
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Primary biliary cholangitis
Phase 1, Completed, NCT07304843, clinicaltrials.gov, 16 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Competitors5
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.